Miris Holding AB (XSAT:MIR) Receipts from Customers

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:MIR Miris Holding AB XSAT:MIR
32 GF Score
Price kr19.60
GF Value kr8.74
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Miris Holding AB Receipts from Customers?

Receipts from Customers only applicable to companies reporting Cash Flow from Operations in direct method.

XSAT:MIR
32GF Score
Miris Holding AB XSAT:MIR
Receipts from Customers is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Miris Holding AB (XSAT:MIR) Overvalued in 2026?

Based on GuruFocus' analysis, Miris Holding AB stock appears to be overvalued. The current stock price of kr19.60 is trading 124.3% above its estimated GF Value™ of kr8.74. GuruFocus considers Miris Holding AB to be Significantly Overvalued.

Key valuation signals for XSAT:MIR:

  • Receipts from Customers:
  • GF Value™: kr8.74 vs. price of kr19.60 (124.3% above fair value)
  • GF Score™: 32/100 with 4 warning signs

No single metric tells the full story. See the XSAT:MIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Miris Holding AB Business Description

Address Danmarksgatan 26, Uppsala, SWE, SE-753 23
Miris Holding AB is a Swedish medical technology company that develops, manufactures, and sells instruments and consumables for the analysis of human milk. Its principal product is the Miris HMA (Human Milk Analyzer), a mid-infrared spectroscopy instrument that measures the macronutrient composition of breast milk, including fat, protein, carbohydrate, and energy content. The company's customers are hospitals, neonatal intensive care units, and human milk banks, which use the analyzer to individualize nutrition for premature and low-birth-weight infants and to classify donated milk. Miris generates revenue through the sale of analyzers and recurring sales of consumables, such as test kits and calibration supplies, along with service and support. The company is headquartered in Uppsala, Sweden, and sells internationally through direct operations and distributor partnerships, with its largest markets in Europe, North America, and Asia.
32GF Score

Get the complete analysis for XSAT:MIR

Receipts from Customers is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr19.60
Price
kr8.74
GF Value